NCT04049266 · Interventional trial
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Overall registry status Terminated
Phase 2 · Phase 3
Conditions Wet Macular Degeneration
Delaware Valley sites
- Wills Eye Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory